OAC
ALNY icon

OMERS Administration Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

OMERS Administration Corp’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Hold
4,517
– – 0.01% 571
2025
Q4 		$1.8M Hold
4,517
– – 0.01% 419
2025
Q3 		$2.06M Hold
4,517
– – 0.01% 403
2025
Q2 		$1.47M Hold
4,517
– – 0.01% 451
2025
Q1 		$1.22M Sell
4,517
-735
-14% -$189K 0.01% 518
2024
Q4 		$1.24M Buy
5,252
+891
+20% +$234K 0.01% 472
2024
Q3 		$1.2M Hold
4,361
– – 0.01% 485
2024
Q2 		$1.06M Buy
+4,361
New +$688K 0.01% 521
2023
Q4 		– Sell
-4,000
Closed -$708K – 294
2023
Q3 		$708K Buy
+4,000
New +$763K 0.01% 104

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return